Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554855-26-000467
Filing Date
2026-03-30
Accepted
2026-03-30 17:29:46
Documents
82
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sxtp-20251231.htm   iXBRL 10-K 3281221
7 EXHIBIT 19.1 ex191_1.htm EX-19.1 77091
8 EXHIBIT 23.1 ex231_2.htm EX-23.1 2667
9 EXHIBIT 31.1 ex311_3.htm EX-31.1 12503
10 EXHIBIT 31.2 ex312_4.htm EX-31.2 12605
11 EXHIBIT 32.1 ex321_5.htm EX-32.1 5179
12 EXHIBIT 32.2 ex322_6.htm EX-32.2 5206
13 GRAPHIC ca35a3a4554a63186c00.jpg GRAPHIC 322082
  Complete submission text file 0001554855-26-000467.txt   15186247

Data Files

Seq Description Document Type Size
2 DEFINITION sxtp-20251231_def.xml EX-101.DEF 708336
3 PRESENTATION sxtp-20251231_pre.xml EX-101.PRE 831450
4 CALCULATION sxtp-20251231_cal.xml EX-101.CAL 122220
5 LABEL sxtp-20251231_lab.xml EX-101.LAB 1558799
6 SCHEMA sxtp-20251231.xsd EX-101.SCH 95197
86 EXTRACTED XBRL INSTANCE DOCUMENT sxtp-20251231_htm.xml XML 1880124
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41719 | Film No.: 26813053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)